UBS AM’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.42M Buy
136,738
+946
+0.7% +$26.7K ﹤0.01% 1767
2025
Q4
$4.27M Buy
135,792
+4,359
+3% +$145K ﹤0.01% 1541
2025
Q3
$4.69M Sell
131,433
-70,018
-35% -$3.2M ﹤0.01% 1398
2025
Q2
$11.6M Buy
201,451
+48,293
+32% +$2.73M ﹤0.01% 1286
2025
Q1
$8.92M Buy
153,158
+13,767
+10% +$940K ﹤0.01% 1280
2024
Q4
$11.2M Buy
139,391
+22,931
+20% +$1.96M ﹤0.01% 1196
2024
Q3
$9.33M Buy
116,460
+3,083
+3% +$219K ﹤0.01% 1261
2024
Q2
$6.93M Buy
113,377
+61,301
+118% +$3.65M ﹤0.01% 1313
2024
Q1
$2.57M Buy
52,076
+7,853
+18% +$374K ﹤0.01% 1553
2023
Q4
$1.85M Buy
44,223
+12,086
+38% +$412K ﹤0.01% 1732
2023
Q3
$1.05M Buy
32,137
+18,552
+137% +$632K ﹤0.01% 1936
2023
Q2
$386K Hold
13,585
﹤0.01% 2399
2023
Q1
$386K Buy
13,585
+1,257
+10% +$44.3K ﹤0.01% 2399
2022
Q4
$512K Buy
+12,328
New +$529K ﹤0.01% 2170

Other funds holding PRCT